Add to Basket
|+1 404 474 4654|
|+1 888 205 9894 (TF)|
Vimentin (VIM) antibody
|Synonyms||FLJ36605, MGC102095, cb28, MGC139781, VIM, vim, Vim, vime|
Human, Mouse (Murine), Rat (Rattus)
Alternatives Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Western Blotting (WB)
|3 references available|
|Quantity||25 µl (Variants)|
|Price||Product not available in this region.|
|Immunogen||The immunogen used to generate our antibody was recombinant vimentin purified fromE. coli.|
|Description||Vimentin is the 10nm or intermediate filament protein subunit found in many kinds ofmesenchymal and epithelia cells, in many kinds of cells in tissue culture and indeveloping neuronal and astrocytic precursor cells in the central nervous system.Vimentin frequently forms copolymers with other intermediate filament proteins, such asGFAP (in many kinds of astrocytes), with desmin (in muscle cells) and neurofilamentproteins (in developing neurons). Antibodies to vimentin are useful in studies of stemcells and generally to reveal the filamentous cytoskeleton. Alternate Names: anti-FLJ36605 antibody, anti-VIM antibody.|
|Specificity||Species Reactivity: ABIN152563 reacts with Vimentin from human, mouse, and rat.|
|Application Notes||Suggested working dilutions: immunofluorescence 1:5000,Immunohistochemistry-Paraffin 1:150|
|Buffer||Preservative: 5mM Sodium Azide.|
|Storage||Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze thaw cycles.|
|Research Area||Lineage Markers, Cytoskeleton, Neural Stem Cell marker, Cell/Tissue Markers|
|Restrictions||For Research Use only|
Rankin, Tomaszewski, Haase: "Renal cyst development in mice with conditional inactivation of the von Hippel-Lindau tumor suppressor." in: Cancer research, Vol. 66, Issue 5, pp. 2576-83, 2006 (PubMed).
Okawa, Michaylira, Kalabis et al.: "The functional interplay between EGFR overexpression, hTERT activation, and p53 mutation in esophageal epithelial cells with activation of stromal fibroblasts induces tumor development, invasion, and differentiation." in: Genes & development, Vol. 21, Issue 21, pp. 2788-803, 2007 (PubMed).
Johnstone, Mongroo, Rich et al.: "Parvin-beta inhibits breast cancer tumorigenicity and promotes CDK9-mediated peroxisome proliferator-activated receptor gamma 1 phosphorylation." in: Molecular and cellular biology, Vol. 28, Issue 2, pp. 687-704, 2008 (PubMed).